Ledger.Open graph →
SEC Form D · filed February 18, 2025

Nanocan Therapeutics Corp

Offering
$6.5M
Sold
$5.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NATIONAL HARBOR, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Dave P. Krasne · NATIONAL HARBOR, MDExecEric C. Broyles · NATIONAL HARBOR, MDExec · DirectorJacques P. Walker · NATIONAL HARBOR, MDExec · DirectorDave P. Krasne · NATIONAL HARBOR, MDExecEric C. Broyles · NATIONAL HARBOR, MDExec · DirectorJacques P. Walker · NATIONAL HARBOR, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗